Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Hera-MI logo — Shaping the future of radiology by making AI & Radiologists...

Hera-MI

Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection

Founded 2017 France France 22 employees Non Equity Assistance AI, Biotechnology +1

General Information

Company Name Hera-MI
Founded Year 2017
Location France France +1
Employees 22
Industries AI, Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

Get notified when Hera-MI moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hera-MI

Hera-MI is a startup based in France founded in 2017 with a mission to shape the future of radiology by utilizing AI and radiologists to enhance early detection of breast cancer. The company is focused on leveraging AI to increase the recovery rate and optimize healthcare treatment for women. Hera-MI is addressing the significant issue of breast cancer, which is one of the leading causes of cancer among women. The early detection of breast cancer is crucial, as almost 90% of patients can recover when diagnosed early. Hera-MI is developing a clinical decision support system that is based on machine learning and medical imaging processing. This system aims to improve the early detection of breast cancer while enhancing the quality and accuracy of diagnosis. Additionally, it reduces the interpretation time for radiologists, thereby improving overall efficiency. The startup's solution not only focuses on technological advancement but also emphasizes patient care improvement. By providing more efficient breast cancer screening, Hera-MI enables women to receive earlier treatment, thereby increasing their chances of recovery. Recently, Hera-MI received non-equity assistance from MassChallenge in an investment round that took place on 21 October 2020. The investment signifies the confidence of the industry in the potential of Hera-MI's innovative approach to revolutionizing breast cancer detection and treatment. With its focus on AI, biotechnology, and healthcare, Hera-MI is poised to make a significant impact on the future of radiology and women's healthcare.

Taxonomy: Breast Cancer, Mammography, Tomosynthesis, MRI, 3D Ultrasound, Elastography, Image Processing, Medical Imaging, Clinical Decision Support System, Senology, CAD, Digital Medical Imaging, Early-stage Diagnosis, Healthcare Innovation

Services & Products

Development of AI-powered software solutions for breast cancer diagnosis and mammography analysis

Target Customers

Radiologists senologists healthcare institutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance - Hera •••••• 1
Investor
21 Oct 2020

Hera-MI Alternatives & Competitors

Hera-MI vs
Koning Health
Koning Health United States

Revolutionizing the breast imaging industry

Equity Crowdfunding
30 employees
Analytics, Health Care
Compare Hera-MI vs Koning Health
Hera-MI vs
Gabbi
Gabbi United States

Making late stage Breast Cancer obsolete

Seed
23 employees
Health Care, Health and Wellness
Hera-MI vs
U-Systems
U-Systems

Innovative ultrasound systems and software crafted to aid radiologists in breast cancer detection fo...

Series Unknown
Medical Devices

FAQ About Hera-MI

Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection
Hera-MI was founded in 2017.
Hera-MI is headquartered in France.
Hera-MI operates in the following industries: AI, Biotechnology, Health Care.
Hera-MI has approximately 22 employees.
Hera-MI has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Hera-MI offers: Development of AI-powered software solutions for breast cancer diagnosis and mammography analysis.
Top alternatives and competitors to Hera-MI include Koning Health, Gabbi, U-Systems, Qview Medical, Inc., Halo Healthcare, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hera-MI and Koning Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hera-MI and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy